Ta-Jen Liu
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, Oncology, Medicine and SurgeryGoogle:
"Ta-Jen Liu"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu TJ, Koul D, LaFortune T, et al. (2009) NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Molecular Cancer Therapeutics. 8: 2204-10 |
| Nakamizo A, Amano T, Zhang W, et al. (2008) Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis. Neuro-Oncology. 10: 275-91 |
| Liu TJ, LaFortune T, Honda T, et al. (2007) Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Molecular Cancer Therapeutics. 6: 1357-67 |
| Puchades M, Nilsson CL, Emmett MR, et al. (2007) Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression. Journal of Proteome Research. 6: 869-75 |
| de Groot JF, Liu TJ, Fuller G, et al. (2005) The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Research. 65: 1934-40 |
| Li AA, Ng E, Shi W, et al. (2004) Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 110: 452-8 |
| Gomez-Manzano C, Balague C, Alemany R, et al. (2004) A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene. 23: 1821-8 |
| Cerrato JA, Khan T, Koul D, et al. (2004) Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas. International Journal of Oncology. 24: 409-17 |
| Lee AW, Li JH, Shi W, et al. (2003) p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma. Molecular Cancer Therapeutics. 2: 961-9 |
| Yan DH, Abramian A, Li Z, et al. (2003) P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochemical and Biophysical Research Communications. 303: 219-22 |